Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Hilus Pulmonary Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 117 Oxaliplatin 111 Fluorouracil 100 Capecitabine 90 Docetaxel 69 Leucovorin 60 Irinotecan 57 Paclitaxel 49 S 1 (combination) 38 pembrolizumab 35 Trastuzumab 31 Radiotherapy 25 Bevacizumab 20 Nivolumab 19 Epirubicin 19 titanium silicide 18 Surgical Procedures, Operative 17 Carboplatin 17 Ramucirumab 16 Cetuximab 15 Gastrectomy 13 apatinib 12 Everolimus 12 Gemcitabine 11 Albumin-Bound Paclitaxel 10 Neoadjuvant Therapy 8 Folfox protocol 8 Drug Therapy 8 Chemotherapy, Adjuvant 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × Electroporation × Clear all

NCT02430636 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡